Name: 글로벌 시장 동향
SKU: MD6133
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 유방 재건 시장은 2022년 5억 7,433만 달러 규모에 달했으며, 2030년까지 9억 3,430만 달러에 이르러 높은 성장세를 보일 것으로 예상됩니다. 이 시장은 예측 기간(2023~2030년) 동안 연평균 6.4%의 성장률을 기록할 것으로 전망됩니다.
유방 재건은 유방 절제술 후 유방을 정상에 매우 가까운 상태로 되돌리기 위해 여러 가지 성형외과 기법을 사용합니다. 유방 재건에는 크게 보형물 재건과 피판 재건 두 가지 유형이 있습니다. 보형물 재건은 새로운 유방 모양을 만들기 위해 유방 보형물을 사용하는 반면, 피판(또는 자가) 재건은 환자 자신의 신체 다른 부위에서 조직을 채취하여 새로운 유방을 만듭니다.
시장 동향
유방 재건 치료에 대한 인식 증가가 유방 재건 시장 성장을 견인하고 있습니다.
이러한 인식 증가는 관련 기관 및 시장 참여자들의 노력에 기인합니다. 예를 들어, 2021년 10월 22일, 임플란트 제조업체인 애브비(AbbVie)는 유방 재건의 가능성을 보여주는 캠페인을 시작했습니다. 새로운 "파워 오브 유(Power of You)" 캠페인을 통해 유방 임플란트 제조업체인 애브비는 이러한 상황을 바꾸고자 합니다. 이 캠페인은 환자들의 용기와 내면의 강인함을 기리는 동시에 유방 재건에 대한 다양한 선택지를 제공합니다. 캠페인 자체는 특정 브랜드를 내세우지 않았지만, 애브비의 유방 재건 제품에는 조직 확장기, 임플란트 전달 슬리브, 그리고 나트렐(Natrelle) 브랜드 임플란트가 포함됩니다.
또한, 유방 재건에 대한 인식을 높이기 위해 타타 메모리얼 센터(Tata Memorial Centre)는 2022년 2월 17일 "재건 및 암 치료: 암과 함께 그리고 암 이후 삶의 질 향상"이라는 제목의 컨퍼런스를 개최했습니다. 이러한 요인들로 인해 유방 재건 시장은 예측 기간 동안 성장을 주도할 것으로 예상됩니다.
3D 프린팅 임플란트 개발은 상당한 상업적 확장 가능성을 제시할 수 있습니다.
3D 프린팅 임플란트 개발은 상당한 상업적 확장 가능성을 제시할 수 있습니다. 예를 들어, 2023년 4월 6일, CollPlant와 Stratasys는 바이오프린팅 기술을 이용해 유방 보형물을 제작할 예정입니다. CollPlant와의 협력을 통해 이 회사는 바이오프린팅 기술을 활용하여 의료 서비스를 혁신하고 유방 확대 또는 재건 수술을 받는 환자들의 삶의 질을 향상시킬 수 있는 중요한 기회를 갖게 되었습니다.
바이오프린팅 기술 개발을 촉진하기 위해 CollPlant와 Stratasys는 공동 개발 및 상용화 계약을 체결했습니다. 이 협력을 통해 Stratasys의 P3 기술 기반 바이오프린터와 CollPlant의 rhCollagen 기반 바이오 잉크를 결합할 것입니다. P3(Programmable PhotoPolymerization)는 유용한 최종 사용 부품의 대량 생산을 위해 개발된 디지털 광처리(DLP) 기술입니다.
COVID-19 영향 분석
시장은 특히 팬데믹 초기 단계에 COVID-19 팬데믹의 영향을 일시적으로 받았습니다. 제한 조치와 봉쇄로 인해 진행 중이거나 예정된 수술이 연기되거나 취소되면서 유방 보형물 시장의 성장이 저해되었습니다. 하지만 미국 여성들 사이에서는 코로나19 팬데믹 기간 동안 유방 확대 및 보형물 삽입을 포함한 외모에 대한 관심과 인식이 높아졌습니다. 그 결과, 시장은 코로나19 팬데믹의 영향에서 회복되어 성장할 것으로 예상됩니다.
러시아-우크라이나 전쟁 영향 분석
러시아-우크라이나 전쟁은 해당 지역의 낮은 발병률과 주요 시장 참여자의 부재로 인해 세계 유방 재건 시장에 미치는 영향이 미미할 것으로 예상됩니다. 그러나 원자재, 검사 제품 및 의료기기의 수출입은 예측 기간 동안 세계 유방 재건 시장에 약간의 영향을 미칠 것으로 예상됩니다.
인공지능 영향 분석
인공지능은 세계 유방 재건 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. 이는 세계 최초의 유방 재건 및 암 수술을 위한 공동 의사 결정 도구인 Breast Advocate 앱 덕분입니다. 이 앱은 유방암 진단을 받았거나 유방암 발병 위험이 있는 모든 사람이 수술 관련 결정에 참여할 수 있도록 무료로 제공됩니다. 이 앱은 유방암 전문의와 환자 운동가들이 공동으로 개발했습니다.

시장 세분화 분석
전 세계 유방 재건 시장은 제품 유형, 모양, 위치, 최종 사용자 및 지역별로 세분화됩니다.
원형 보형물 부문은 예측 기간 동안 유방 재건 시장 점유율의 대부분을 차지할 것으로 예상됩니다.
원형 보형물은 다양한 인허가 기관의 신제품 승인으로 인해 예측 기간 동안 전체 유방 재건 시장의 약 56%를 차지할 것으로 전망됩니다. 이러한 지배력은 신제품 발표 증가, FDA의 유방 보형물 안전성 관련 정기적인 업데이트, 그리고 여러 임상 연구 수행에 기인한 것으로 분석됩니다.
예를 들어, GC Aesthetics는 2021년 5월에 차세대 원형 실리콘 유방 보형물인 PERLE을 출시할 예정입니다. 유방 보형물 수술을 받는 환자들이 충분한 정보를 얻을 수 있도록 미국 FDA는 2021년 10월에 유방 보형물 안전 지침을 개정하고 유방 보형물의 판매 및 유통을 금지했습니다. 따라서 앞서 언급한 요인들로 인해 원형 유방 보형물의 시장이 크게 성장할 것으로 예상됩니다.

지리적 분석
아시아 태평양 지역은 예측 기간 동안 전 세계 유방 재건 시장에서 두 번째로 큰 점유율을 차지할 것으로 예상됩니다.

아시아 태평양 지역은 예측 기간 동안 전 세계 유방 재건 시장에서 약 33%의 점유율을 차지하며 두 번째로 큰 시장 점유율을 기록할 것으로 전망됩니다. 유방 재건 수술에 대한 인식 증가와 급증하는 유방암 발병률이 이러한 성장의 주요 원인입니다.
예를 들어, NCBI 데이터에 따르면 중국에서는 약 303,600건의 유방암 신규 발병 사례와 70,400명의 사망자가 발생했습니다. 또한, 유사한 자료에 따르면 인구 구조 변화와 위험 요인으로 인해 중국의 유방암 발병률과 사망률은 2030년까지 증가할 것으로 예측됩니다. 비슷한 연구 자료에 따르면 유방 절제술 후 유방 재건을 선호하는 여성의 비율은 76.5% 이상입니다.

경쟁 환경
시장의 주요 글로벌 업체로는 Allergan Plc, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion, Mentor Worldwide LLC 등이 있습니다.
보고서 구매 이유

• 제품 유형, 형태, 위치, 최종 사용자 및 지역별 글로벌 유방 재건 시장 세분화를 시각화하고 주요 상업 자산 및 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 모색합니다.

• 모든 세그먼트를 포함한 유방 재건 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석을 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품 정보를 담은 Excel 파일 형태의 제품 맵핑을 제공합니다.

글로벌 유방 재건 시장 보고서는 약 69개의 표, 66개의 그림, 그리고 195페이지 분량으로 구성될 예정입니다.
주요 대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The global breast reconstruction market reached US$ 574.33 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 934.30 million by 2030. The market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).
Breast reconstruction uses several plastic surgical techniques to return a breast to a state that is very close to normal after a mastectomy. Implant-based reconstruction and flap reconstruction are the two main types of breast reconstruction. Breast implants are used in implant reconstruction to create a new breast mound. Flap (or autologous) reconstruction creates a new breast using the patient's own tissue from another area of the body.
Market Dynamics
Growing Awareness About Breast Reconstruction Treatment is Driving the Breast Reconstruction Market Growth.
The increase in awareness can be attributed to actions made by independent bodies and market participants. For instance, on October 22, 2021, AbbVie, an implant manufacturer, develops a campaign to showcase reconstruction possibilities. With its new "Power of You" campaign, the breast implant manufacturer hopes to change that. The initiative honors patients' bravery and inner fortitude while educating them on their options for breast reconstruction. Although the campaign is unbranded, the company's breast reconstruction products include tissue expanders, implant delivery sleeves, and Natrelle-branded implants.
Additionally, to raise awareness of breast reconstruction, Tata Memorial Centre organized a conference titled Reconstruction and Cancer Care: Enhancing Quality Living with and Beyond Cancer on February 17, 2022. As a result of the aforementioned factors, the breast reconstruction market is anticipated to lead throughout the forecast period.
The Development of 3D-printed Implants May Present Considerable Prospects for Commercial Expansion.
The development of 3D-printed implants may present considerable prospects for commercial expansion. For instance, on April 06, 2023, Breast implants will be bioprinted by CollPlant and Stratasys. The company has a significant chance to use bioprinting to alter healthcare and better the lives of patients undergoing breast augmentation or repair treatments thanks to its cooperation with CollPlant.
To advance the development of bioprinting technology, CollPlant, and Stratasys inked a combined development and commercialization agreement. The collaboration will pair Stratasys' P3 technology-based bioprinter with CollPlant's rhCollagen-based bio-inks. Programmable PhotoPolymerization, also known as P3, is a development of digital light processing (DLP) technology intended for the bulk manufacturing of useful end-use components.
COVID-19 Impact Analysis
The market was temporarily impacted by the COVID-19 pandemic, mostly during the pandemic's early stages. The ongoing and scheduled surgical procedures were postponed or canceled as a result of the limitations and lockout, which hampered the expansion of the breast implant market. However, during the COVID-19 pandemic among women in the United States, interest and growing awareness regarding physical appearance, including breast augmentation and implants, increased. As a result, the market is anticipated to rebound from the COVID-19 pandemic's effects and develop.
Russia-Ukraine War Impact Analysis
The Russia-Ukraine is estimated to have a minimal impact on the global breast reconstruction market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global Breast reconstruction market in the forecast period.
Artificial Intelligence Impact Analysis
Artificial intelligence is anticipated to impact the global breast reconstruction market positively owing to the Breast Advocate app being the first shared decision-making tool for breast reconstruction and cancer surgery in the world. It is a free app that gives anybody with a breast cancer diagnosis or at risk of getting breast cancer a voice in the choices made about their surgery. It was co-created by breast cancer doctors and patient activists.
Segment Analysis
The global breast reconstruction market is segmented based on product type, shape, placement, end-user, and region.
The Round Shape Segment is Estimated to Hold a Majority of the Breast Reconstruction Market Share During the Forecast Period.
The round shape holds about 56% of the total breast reconstruction market in the forecast period owing to the acceptance of new products by different permitting bodies. The dominance can be due to the increase in product announcements, the FDA's regular updates on the safety of breast implants, and the execution of several clinical investigations.
For instance, GC Aesthetics will introduce the PERLE, a new generation of round silicone breast implants, in May 2021. In order to ensure that patients undergoing breast implant surgery have enough information, the U.S. FDA amended its safety guidelines for breast implants in October 2021 and prohibited the sales and distribution of breast implants. Therefore, round-shaped breast implants are anticipated to experience significant growth as a result of the aforementioned factors.
Geographical Analysis
Asia Pacific is Estimated to Hold the Second-largest Share of the Global Breast Reconstruction Market During the Forecast Period.
The Asia Pacific region holds the second largest share of the global breast reconstruction market accounting for approximately 33% in the forecast period. The rise in awareness of breast reconstruction surgery and the fast-rising breast cancer population are both responsible for the growth.
For instance, the NCBI data revealed that there were approximately 303,600 new instances of breast cancer and 70,400 fatalities from the disease in China. Furthermore, according to a similar source, the incidence rate and mortality rate in China are predicted to rise by 2030 due to changing demographics and risks. More than 76.5% of women preferred breast reconstruction following mastectomy, according to research by a similar source.
Competitive Landscape
The major global players in the market include Allergan Plc, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion, and Mentor Worldwide LLC, among others.
Why Purchase the Report?
• To visualize the global breast reconstruction market segmentation based on product type, shape, placement, end user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of breast reconstruction market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global Breast reconstruction market report would provide approximately 69 tables, 66 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Shape
3.3. Snippet by Placement
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing prevalence of breast cancer worldwide is expected to drive market growth.
4.1.1.2. Growing Awareness about breast reconstruction treatment
4.1.2. Restraints
4.1.2.1. The high cost of breast surgical procedures is expected to hamper the market growth
4.1.3. Opportunity
4.1.3.1. The introduction of 3D-printed implants may present significant advantages market expansion opportunities
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Before COVID-19 Scenario
6.1.2. Present COVID-19 Scenario
6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Impact Analysis
9. By Product Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.1.2. Market Attractiveness Index, By Product Type
9.2. Implants
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Tissue Expander
9.4. Acellular Dermal Matrix
10. By Shape
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
10.1.2. Market Attractiveness Index, By Shape
10.2. Round Shape
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Anatomical Shape
11. By Placement
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
11.1.2. Market Attractiveness Index, By Placement
11.2. Dual Plane Insertion
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Subglandular Insertion
11.4. Submuscular Insertion
12. By End User
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.1.2. Market Attractiveness Index, By End User
12.2. Hospitals
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Ambulatory Surgical Centers
12.4. Others
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. The U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. The U.K.
13.3.7.3. France
13.3.7.4. Italy
13.3.7.5. Russia
13.3.7.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. Brazil
13.4.7.2. Argentina
13.4.7.3. Rest of South America
13.5. Asia-Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. China
13.5.7.2. India
13.5.7.3. Japan
13.5.7.4. Australia
13.5.7.5. Rest of Asia-Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Market Share Analysis
14.3. Mergers and Acquisitions Analysis
15. Company Profiles
15.1. Allergan Plc
15.1.1. Company Overview
15.1.2. Product Type Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. Sientra, Inc
15.3. IDEAL IMPLANT INCORPORATED
15.4. Johnson & Johnson
15.5. Establishment Labs S.A.
15.6. GC Aesthetics
15.7. Groupe Sebbin SAS
15.8. Ideal Implant Incorporated
15.9. Laboratoires Arion
15.10. Mentor Worldwide LLC.
LIST NOT EXHAUSTIVE
16. Appendix
16.1. About Us and Services
16.2. Contact Us

언급된 주요 기업들

Allergan Plc, 4.	Key Developments, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion, Mentor Worldwide LLC.

표 목록 (Tables)

List of Tables

Table 1 Global Breast Reconstruction Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Breast Reconstruction Market Value, By Shape, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Breast Reconstruction Market Value, By Placement, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Breast Reconstruction Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Breast Reconstruction Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Breast Reconstruction Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 8 Global Breast Reconstruction Market Value, By Shape, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 10 Global Breast Reconstruction Market Value, By Placement, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 12 Global Breast Reconstruction Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 14 Global Breast Reconstruction Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Breast Reconstruction Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 17 North America Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 18 North America Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 19 North America Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 20 North America Breast Reconstruction Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 22 South America Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 23 South America Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 24 South America Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 25 South America Breast Reconstruction Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 27 Europe Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 28 Europe Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 29 Europe Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 30 Europe Breast Reconstruction Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Breast Reconstruction Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Breast Reconstruction Market Value, By Product Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Breast Reconstruction Market Value, By Shape, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Breast Reconstruction Market Value, By Placement, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Breast Reconstruction Market Value, By End User, 2021-2030 (US$ Million)

Table 40 Allergan Plc: Overview

Table 41 Allergan Plc: Product Portfolio

Table 42 Allergan Plc: Key Developments

Table 43 Sientra, Inc: Overview

Table 44 Sientra, Inc: Product Portfolio

Table 45 Sientra, Inc: Key Developments

Table 46 IDEAL IMPLANT INCORPORATED: Overview

Table 47 IDEAL IMPLANT INCORPORATED: Product Portfolio

Table 48 IDEAL IMPLANT INCORPORATED: Key Developments

Table 49 Johnson & Johnson: Overview

Table 50 Johnson & Johnson: Product Portfolio

Table 51 Johnson & Johnson: Key Developments

Table 52 Establishment Labs S.A.: Overview

Table 53 Establishment Labs S.A.: Product Portfolio

Table 54 Establishment Labs S.A.: Key Developments

Table 55 GC Aesthetics: Overview

Table 56 GC Aesthetics: Product Portfolio

Table 57 GC Aesthetics: Key Developments

Table 58 Groupe Sebbin SAS: Overview

Table 59 Groupe Sebbin SAS: Product Portfolio

Table 60 Groupe Sebbin SAS: Key Developments

Table 61 Ideal Implant Incorporated: Overview

Table 62 Ideal Implant Incorporated: Product Portfolio

Table 63 Ideal Implant Incorporated: Key Developments

Table 64 Laboratoires Arion: Overview

Table 65 Laboratoires Arion: Product Portfolio

Table 66 Laboratoires Arion: Key Developments

Table 67 Mentor Worldwide LLC: Overview

Table 68 Mentor Worldwide LLC: Product Portfolio

Table 69 Mentor Worldwide LLC: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 2 Global Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 4 Global Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 5 Global Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 6 Global Breast Reconstruction Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Breast Reconstruction Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Implants Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 9 Tissue Expander Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 10 Acellular Dermal Matrix Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 11 Global Breast Reconstruction Market Y-o-Y Growth, By Shape, 2022-2030 (%)

Figure 12 Round Shape in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 13 Anatomical Shape in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 14 Global Breast Reconstruction Market Y-o-Y Growth, By Placement, 2022-2030 (%)

Figure 15 Dual Plane Insertion Placement in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 16 Subglandular Insertion Placement in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 17 Submuscular Insertion Placement in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 18 Global Breast Reconstruction Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 19 Hospitals End User in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 20 Ambulatory Surgical Centers End User in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 21 Others End User in Global Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 22 Global Breast Reconstruction Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 23 North America Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 24 Asia-Pacific Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 25 Europe Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 26 South America Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 27 Middle East and Africa Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 28 North America Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 29 North America Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 30 North America Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 31 North America Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 32 North America Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 33 North America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 34 North America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 35 North America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 36 North America Breast Reconstruction Market Share, By Country, 2022 & 2030 (%)

Figure 37 South America Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 38 South America Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 39 South America Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 40 South America Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 41 South America Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 42 South America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 43 South America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 44 South America Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 45 South America Breast Reconstruction Market Share, By Country, 2022 & 2030 (%)

Figure 46 Europe Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 47 Europe Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 48 Europe Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 49 Europe Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 50 Europe Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 51 Europe Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 52 Europe Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 53 Europe Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 54 Europe Breast Reconstruction Market Share, By Country, 2022 & 2030 (%)

Figure 55 Asia-Pacific Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 56 Asia-Pacific Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 57 Asia-Pacific Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 58 Asia-Pacific Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 59 Asia-Pacific Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 60 Asia-Pacific Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 61 Asia-Pacific Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 62 Asia-Pacific Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 63 Asia-Pacific Breast Reconstruction Market Share, By Country, 2022 & 2030 (%)

Figure 64 Middle East & Africa Breast Reconstruction Market Value, 2021-2030 (US$ Million)

Figure 65 Middle East & Africa Breast Reconstruction Market Share, By Product Type, 2022 & 2030 (%)

Figure 66 Middle East & Africa Breast Reconstruction Market Share, By Shape, 2022 & 2030 (%)

Figure 67 Middle East & Africa Breast Reconstruction Market Share, By Placement, 2022 & 2030 (%)

Figure 68 Middle East & Africa Breast Reconstruction Market Share, By End User, 2022 & 2030 (%)

Figure 69 Middle East & Africa Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 70 Middle East & Africa Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 71 Middle East & Africa Breast Reconstruction Market Share, By, 2022 & 2030 (%)

Figure 72 Allergan Plc: Financials

Figure 73 Sientra, Inc: Financials

Figure 74 IDEAL IMPLANT INCORPORATED: Financials

Figure 75 Johnson & Johnson: Financials

Figure 76 Establishment Labs S.A.: Financials

Figure 77 GC Aesthetics: Financials

Figure 78 Groupe Sebbin SAS: Financials

Figure 79 Ideal Implant Incorporated: Financials

Figure 80 Laboratoires Arion: Financials

Figure 81 Mentor Worldwide LLC: Financials

세계 유방 재건 시장 – 2023-2030

Global Breast Reconstruction Market - 2023-2030